Pulmonary fibrosis is characterized by excessive fibroblast proliferation and abnormal collagen deposition [1, 4, 8, 18, 26–30], which has similar pathological process to cancer. Although anoikis was shown to have important role in cancer progression [10, 17, 31–33], the role of anoikis in pulmonary fibrosis remains unclear. The current study revealed a unique model of anoikis in pulmonary fibroblasts, which depends on both resistance to anoikis and decreased adherence to the ECM, suggesting a tight connection between fibroblast proliferation and abnormal collagen deposition. These results indicate a vital role of anoikis resistance in fibroblast proliferation during pulmonary fibrosis.
In the current study, silica was applied to establish the pulmonary fibrosis model, which is a typical form of chronic pulmonary fibrosis [34, 35] and mimics the clinical symptoms of fibrosis, such as silicosis. Silicosis is one of the major occupational diseases worldwide and is caused by long-term inhalation of SiO2, with pulmonary fibrosis as the outcome [36]. Although many studies have been performed, the mechanism of pulmonary fibrosis in silicosis has not yet been established. China has the largest number of silicosis patients in the world, and due to the large population, the number of these patients is increasing annually. Therefore, elucidation of the etiology of silicosis is still underway. Silica-induced pulmonary fibrosis is related to the particle size of SiO2 inhaled [37]. Compared with most nontoxic nano-SiO2 particles, micro-scaled SiO2 particles have a strong ability to induce fibrosis, with fibrotic nodules appearing after 30–60 days in exposed mice. Unfortunately, micron-scaled SiO2 particles are more common pollutants in occupational environments [34]. In this study, SiO2 particles with a diameter of approximately 5 µm were used as the main irritant, which helped clarify the specific process of pulmonary fibrosis with a similar mechanism.
Fibroblast proliferation is the main pathological process in pulmonary fibrosis [1, 38, 39] and may be due to either an increase in cell number or a decrease in cell death. A recent study suggested a direct effect of SiO2 on fibroblast proliferation, which was mainly caused by a decrease in apoptosis of fibroblasts via ERS [40]. Interestingly, CM from macrophages exposed to SiO2 did not show any significant effect on apoptosis of fibroblasts, indicating a different effect of the inflammatory environment compared to the direct effect of SiO2 on fibroblasts. Apoptosis mainly occurs in pulmonary macrophages after phagocytosis of silica particles (also known as dust cells), followed by an inflammatory cascade at the early stage. Dust cells undergo apoptosis and release SiO2 particles again, forming a vicious cycle with the release of inflammatory factors, which leads to alveolar epithelial injury and fibroblast activation [29, 41]. Furthermore, SiO2 particles in the alveoli that directly contact epithelial cells can cause edema and necrosis [28]. Loss of epithelial cells leads to exposure of the lung interstitium, upon which lung fibroblasts migrate outward and are activated into myofibroblasts under the direct and indirect activities of SiO2 [39]. Obviously, multiple mechanisms, such as classical apoptosis, necrosis, or ferroptosis, are involved in excessive proliferation of fibroblasts. Notably, as a type of mesenchymal cell, fibroblasts are strongly affected by the environment, such as the ECM. As shown in current study, inflammatory factors released by macrophages exacerbated apoptosis in detached fibroblasts, indicating excessive proliferation of fibroblasts should be a comprehensive result of direct and indirect effects produced by either macrophages or ECM. Moreover, the specific increase in the anoikis resistance marker NTRK2 suggested a unique interaction between fibroblasts and ECM during pulmonary fibrosis.
Increasing evidence suggested that the ECM can regulate cell function, fate and phenotype in a physiological setting, while the composition and function of the ECM are obviously disordered in pathological tissue remodeling [42]. Anoikis is a physiological protective mechanism to prevent excessive proliferation of fibroblasts detached from ECM [5, 33], which may be caused by disruption of the integrin signaling pathway in fibroblasts [31] or changes in the components within the fibrotic ECM. There are few reports about the global changes of proteins in the ECM during pulmonary fibrosis, and thus, proteomics was utilized to analyze the change in the protein profile of the ECM after SiO2 exposure. As expected, various proteins involved in mediating cell-ECM adhesions showed downregulated expression, indicating the initiation of anoikis and suggesting that detachment and proliferation in anoikis resistance experienced by fibroblasts are two independent events that need to be investigated separately.
ZC3H4, a novel member of zinc finger protein family, has been shown to play a key role in anoikis resistance in fibroblasts since a recent study suggested a role of zinc finger proteins in anoikis in different conditions [32, 33]; for example, ZNF32 and ZNF304 promoted abnormal tissue repair and mitigated tumor cell metastasis via anoikis resistance. Accordingly, both ZC3H12A and ZC3H4 are involved in progression of pulmonary fibrosis [12, 13, 15, 16, 20], but the connection to anoikis is still unclear. In this study, ZC3H4 was observed to regulate the anoikis resistance of fibroblasts and participate in pulmonary fibrosis. Since both autophagy [43–45] and ERS [46–48] play an important role in the tissue fibrosis, as well regulation of abnormal protein expression, the connection between ZC3H4 and autophagy/ERS was investigated. In addition, the signaling pathway of ZC3H4 was verified, in which MAPK/PI3K signaling promoted anoikis resistance, followed by pulmonary fibrosis.
In summary, SiO2 induced the synergistic action of macrophage-derived inflammatory factors that promoted detached fibroblasts from the ECM the undergo proliferation, named anoikis resistance, following persistent and irreversible pulmonary fibrosis. ZC3H4 mediated anoikis resistance with ERS and MAPK/PI3K signaling pathway activation (Figure 8). The results of this study suggest that anoikis resistance is highly associated with fibrosis and has abnormal activity during the repair of abnormal lung tissue.
Our study showed that fibroblasts exhibit detachment and anoikis resistance in lung tissues during fibrosis. The zinc finger protein ZC3H4 regulates the development of anoikis resistance in fibroblasts, and its expression is increased during fibrosis. The PI3K and MAPK signaling pathways are activated during pulmonary fibrosis, and anoikis resistance is regulated by ZC3H4 (Figure 8). Thus, a combination therapy targeting key inflammatory factors, growth-promoting factors, and epigenetic modifications may be the most successful strategy for treating highly complex and devastating fibrotic diseases.